Pharmaceutical

Newron and Myung In Pharm sign agreement for evenamide development

Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.

Jan 10, 2025 - 06:00
Newron and Myung In Pharm sign agreement for evenamide development
Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.
Read the original article

Tags:

Previous Article

Groundbreaking Protein Study Launch Promises to Transform Medical Science

Next Article

Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: While other states, countries have biotech envy, Massachusetts can’t find enough workers

STAT+: While other states, countries have biotech envy,...

Jun 8, 2023

CT-080 by First Condor Group for Solid Tumor: Likelihoo...

Oct 3, 2023

Ending racial health disparities hinges on penalties, political will, experts say

Ending racial health disparities hinges on penalties, p...

Jul 12, 2023